Recent Finacing
Recent Raise
OncoCell MDx develops and commercializes noninvasive RNA-Seq immunogenomics blood assays and a >2,000‑subject database to detect, grade, and serially monitor aggressive prostate cancer and other diseases.
Recent Investors
Total Raised
Funding round
Investor
See the team members at OncoCell MDx.
